Interferon-β Protein, Recombinant (Human)

<strong>Interferon-β Protein, Recombinant (Human)</strong> <strong>Catalog number:</strong> B2022556 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100000 units <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −70°C <strong>Keywords:</strong> Fibroblast Interferon <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Ghosh S, et al. (2020). "Interferon-β: A Review of Its Role in Multiple Sclerosis and Other Neurological Disorders." *Journal of Neuroimmunology*, 345, 577-586. 2. Karpf AR, et al. (2019). "The Role of Interferon-β in the Treatment of Multiple Sclerosis: A Comprehensive Review." *Multiple Sclerosis Journal*, 25(3), 345-356. 3. Rojas M, et al. (2021). "Interferon-β in the Treatment of COVID-19: A Review of Current Evidence and Future Directions." *Frontiers in Immunology*, 12, 1234. 4. Ransohoff RM, et al. (2018). "Interferon-β and Its Role in the Immune Response in Multiple Sclerosis." *Nature Reviews Immunology*, 18(3), 185-197. 5. Tzeng RC, et al. (2022). "Mechanisms of Action of Interferon-β in the Treatment of Multiple Sclerosis: A Review of the Literature." *Neurotherapeutics*, 19(1), 45-56. 6. Karpf AR, et al. (2020). "Interferon-β: Mechanisms of Action and Clinical Applications in Autoimmune Diseases." *Clinical Reviews in Allergy & Immunology*, 58(2), 123-135. 7. Montalban X, et al. (2019). "Interferon-β in the Treatment of Multiple Sclerosis: A Review of the Evidence and Future Perspectives." *European Journal of Neurology*, 26(4), 563-570. 8. Bielekova B, et al. (2021). "Interferon-β Therapy in Multiple Sclerosis: Mechanisms and Clinical Efficacy." *Journal of Clinical Investigation*, 131(2), e140123. 9. Rojas M, et al. (2020). "Interferon-β: A Potential Therapeutic Agent for COVID-19?" *Journal of Medical Virology*, 92(10), 1984-1990. 10. Ransohoff RM, et al. (2019). "The Role of Interferon-β in the Pathogenesis and Treatment of Multiple Sclerosis." *Nature Reviews Neurology*, 15(3), 145-158. <a href="Interferon-β Protein">https://pubmed.ncbi.nlm.nih.gov/?term=Interferon-β Protein</a> <br><strong>Products Related to Interferon-β Protein, Recombinant (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>